Finally Some Good News as the FDA Lifts Hold on Sanofi, Alnylam's Fitusiran Post author:Sam Post published:December 14, 2017 Post category:BioPharma Clinical trial dosing will resume around year-end 2017. Source: BioSpace You Might Also Like Quest Diagnostics Declares Quarterly Cash Dividend August 17, 2017 Vanda Release: Company To Announce Fourth Quarter And Full Year 2016 Financial Results On February 15, 2017 January 19, 2017 Massive FDA and NIH Cuts in Outlined Budget Plan May 22, 2017
Vanda Release: Company To Announce Fourth Quarter And Full Year 2016 Financial Results On February 15, 2017 January 19, 2017
